Hydroxamate-based inhibitors of low affinity IgE receptor (CD23) processing

Bioorg Med Chem Lett. 1998 Jan 6;8(1):23-8. doi: 10.1016/s0960-894x(97)10148-2.

Abstract

A series of hydroxamic acids related to the non-selective matrix metalloprotease inhibitor Batimastat is described, which inhibits the proteolytic cleavage of the low affinity IgE receptor from cell membrane preparations. Limited SAR studies suggest that the structural requirements for effective inhibition are distinct from those required for the inhibition of collagenase.

MeSH terms

  • Humans
  • Hydroxamic Acids / chemistry
  • Hydroxamic Acids / pharmacology*
  • Phenylalanine / analogs & derivatives
  • Phenylalanine / pharmacology
  • Protease Inhibitors / pharmacology
  • Protein Processing, Post-Translational / drug effects*
  • Receptors, IgE / antagonists & inhibitors*
  • Receptors, IgE / metabolism
  • Structure-Activity Relationship
  • Thiophenes / pharmacology

Substances

  • Hydroxamic Acids
  • Protease Inhibitors
  • Receptors, IgE
  • Thiophenes
  • Phenylalanine
  • batimastat